The source shelf
Go to the record behind the answer.
Use these sources when a product name, a licence, or a payment term needs checking.
Read the date beside a changing answer
The prices, rules, safety information, and care processes described here were checked in September 2026.
For a decision today, ask the service and the relevant board or program to confirm the current position. Keep the reply with the quote.
Check the medicine and how it is made
Check the product record
Start with the exact product name. Read what it is approved to treat and whether it comes as an injection, a tablet, or another form before comparing claims.
Read why compounding is different
Compounded preparations lack FDA approval as of September 2026, even when they serve a patient’s need through compounding.
Check the licence and the care process
Find public licence records
The medical-board directory links to the boards that hold doctor records, and FDA links to state pharmacy searches.
Use the name of the actual person treating you or pharmacy. Match the record carefully; a badge is not the record.
Read the guidance about care visits
The Federation of State Medical Boards advises the state boards that oversee doctors. Its guidance helps those boards decide on rules; it does not itself set a national prescribing law.
Check the Medicare program terms
The temporary Medicare program’s dates, eligibility, and costs need to be read together.
Its terms checked in September 2026 provide a $50 monthly copay for eligible people through December 31, 2027.
- Medicare GLP-1 Bridge: program overview
- Medicare GLP-1 Bridge: eligibility and covered products
- Government cash-price listing for semaglutide (Ozempic) injection
- IRS: medical expenses and general health
Blood sugar and appetite are influenced by the hormone GLP-1; these program pages use its name for a group of medicines.
Find handling, urgent-help, and reporting information
- US National Library of Medicine: semaglutide injection
- US National Library of Medicine: severe allergic reactions
- FDA MedWatch: report a medical-product problem
Patients and health professionals can both send reports to MedWatch.